Bay Harbor Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.7K Buy
2,605
+2,024
+348% +$52.9K 0.01% 137
2026
Q1
$16.3K Buy
581
+183
+46% +$4.87K ﹤0.01% 168
2025
Q4
$9.91K Buy
398
+147
+59% +$3.71K ﹤0.01% 182
2025
Q3
$6.39K Buy
251
+54
+27% +$1.33K ﹤0.01% 174
2025
Q2
$4.78K Buy
197
+92
+88% +$2.15K ﹤0.01% 183
2025
Q1
$2.66K Buy
+105
New +$2.75K ﹤0.01% 173
2021
Q4
Sell
-76
Closed -$3K 194
2021
Q3
$3K Sell
76
-718
-90% -$31.8K ﹤0.01% 175
2021
Q2
$31K Sell
794
-973
-55% -$37.8K 0.01% 145
2021
Q1
$64K Sell
1,767
-1,360
-43% -$48.3K 0.03% 121
2020
Q4
$115K Sell
3,127
-2,764
-47% -$101K 0.05% 94
2020
Q3
$205K Sell
5,891
-2,852
-33% -$100K 0.1% 73
2020
Q2
$271K Sell
8,743
-1,615
-16% -$54.9K 0.14% 77
2020
Q1
$321K Sell
10,358
-1,663
-14% -$56.7K 0.19% 57
2019
Q4
$447K Buy
12,021
+2,856
+31% +$102K 0.24% 55
2019
Q3
$312K Buy
9,165
+6,271
+217% +$228K 0.19% 70
2019
Q2
$119K Buy
2,894
+1,757
+155% +$69.8K 0.07% 112
2019
Q1
$46K Sell
1,137
-265
-19% -$10.6K 0.03% 166
2018
Q4
$58K Buy
+1,402
New +$58.2K 0.05% 142

Other funds holding PFE

Bay Harbor Wealth Management's PFE Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Pfizer (PFE) stake by 348% in Q2 2026, buying an estimated $52.9K and bringing the position to 2,605 shares worth $62.7K. The position accounts for 0.01% of the portfolio, ranked #137.

Bay Harbor Wealth Management first reported a position in PFE in Q4 2018 and has held it in 18 quarters since. The position peaked at $447K in Q4 2019. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bay Harbor Wealth Management held 2,605 shares of Pfizer worth $62.7K as of Q2 2026.
  • Bay Harbor Wealth Management bought 2,024 Pfizer shares in Q2 2026, an estimated $52.9K.
  • Pfizer made up 0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #137 holding.
  • Bay Harbor Wealth Management first reported a position in Pfizer in Q4 2018 and has held it in 18 quarters since.
  • Bay Harbor Wealth Management's Pfizer position peaked at $447K in Q4 2019.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.